CIK 0001828673 · <br>Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825024477
- Phone
- 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-07 | GARRETT SCOTT T Director | Purchase · Common Stock Purchase Warrant | +2,692 | 2,692 | ||
| 2025-05-07 | Byam Rebecca Chief Financial Officer | Purchase · Common Stock Purchase Warrant | +4,231 | 4,231 | ||
| 2025-05-07 | Flowers Lee SVP of Business Development | Purchase · Common Stock Purchase Warrant | +481 | 481 | ||
| 2025-05-07 | Greene Rick S. Director | Purchase · Common Stock Purchase Warrant | +481 | 481 | ||
| 2024-06-14 | Giles Lisa M. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-06-14 | GARRETT SCOTT T Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-06-14 | Greene Rick S. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-06-14 | Winer Gary M Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2024-02-20 | Wong Hing C Chief Executive Officer | Grant or award | +739,288 | $1.40 | $1.0M | 16,054,156 |
| 2024-02-20 | Greene Rick S. Director | Grant or award | +35,714 | $1.40 | $50K | 44,125 |
| 2024-02-20 | Giles Lisa M. Director | Grant or award | +35,715 | $1.40 | $50K | 35,815 |
| 2024-02-20 | GARRETT SCOTT T Director | Grant or award | +142,858 | $1.40 | $200K | 267,858 |
| 2024-02-20 | Flowers Lee SVP of Business Development | Grant or award | +71,429 | $1.40 | $100K | 190,238 |
| 2024-02-20 | Byam Rebecca Chief Financial Officer | Grant or award | +760,714 | $1.40 | $1.1M | 1,381,909 |
| 2023-12-11 | Rhode Peter See Remarks | Option exercise | +14,000 | $0.14 | $2K | 77,500 |
| 2023-12-11 | Rhode Peter See Remarks | Option exercise · Stock Option (Right to Buy) | −14,000 | 22,427 | ||
| 2023-12-08 | Flowers Lee SVP of Business Development | Option exercise | +7,501 | $0.14 | $1K | 118,809 |
| 2023-12-08 | Flowers Lee SVP of Business Development | Option exercise · Stock Option (Right to Buy) | −7,501 | 0 | ||
| 2023-11-17 | Rhode Peter See Remarks | Option exercise | +15,000 | $0.14 | $2K | 63,500 |
| 2023-11-17 | Rhode Peter See Remarks | Option exercise · Stock Option Grant (Right to Buy) | −15,000 | 36,427 |
Page 2 of 9 · 164 trades